ALID / Allied Corp. - SEC-arkiveringar, Årsredovisning, Fullmaktsutlåtande

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 33-1227173 Allied Corp. (Exact name of registrant as specified in its charte

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2025 (February 3, 2025) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 25

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 25 OMB APPROVAL OMB Number: 3325-0000 Expires: May 31, 2027 Estimated average burden hours per response....1.00 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 0-27675 Allied Corp. (Exact name of Issuer as specified in its charter

Allied Corp Announces Strategic Decision to Voluntarily Cease Quotation and SEC Registration

EXHIBIT 99.1 January 21, 2025 NEWS RELEASE OTCQB: ALID 200 – 400 Doyle Avenue, Kelowna, BC, Canada V1Y OC2 Toll Free: 1-877-255-4337 www.allied.health Allied Corp Announces Strategic Decision to Voluntarily Cease Quotation and SEC Registration Kelowna, BC, Canada – January 21, 2025 Allied Corp. ("Allied" or the "Company") (OTCQB: ALID) today announced that its Board of Directors (the "Board") has

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 22, 2025 (January 21, 2025) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2024 Commission File Number 000-56002 Allied Corp. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation) (I.R.S. Emplo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 FORM 10-K/A (Mark One)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 FORM 10-K/A (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the fiscal year ended August 31, 2024 000-56002 (Commission file number) Allied Corp. (Exact name of registrant as specified in its charte

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the fiscal year ended August 31, 2024 000-56002 (Commission file number) Allied Corp. (Exact name of registrant as specified in its charter) Nevada 33-12271

List of Subsidiaries.

EXHIBIT 21 Subsidiaries of Allied Corp. AM (Advanced Micro) Biosciences, Inc. Allied Colombia S.A.S. Allied US Products, LLC

Notification of Late Filing (incorporated by reference of the Company's filing on Form 10-K with the Securities and Exchange Commission on November 29, 2024)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: August 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Fo

1

EXHIBIT 99.1 November 18 2024 NEWS RELEASE OTCQB: ALID Suite 200 – 460 Doyle Ave Kelowna, BC, Canada V1Y 2E9 Toll Free: 1-877-255-4337 www.allied.health Allied Corp. Completes 30kg Shipment to Portuguese Channel Partner, Initiating United Kingdom Supply Contract Kelowna, BC, Canada – November 18, 2024 Allied Corp ("Allied" or the “Company”) (OTCQB: ALID), a Canadian medical cannabis supplier with

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2024 (November 18, 2024) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-56002 33-1227173 (State or Other Jurisdiction of Incorporation) (Com

CanPoland Spółka Akcyjna Forward Purchase Agreement dated September 26, 2024 (incorporated by reference to Exhibit 10.1 of the Company’s filing on Form 8-K filed with the Securities and Exchange Commission on October 15, 2024)

EXHIBIT 10.1 Forward Purchase Agreement This Agreement (the “Agreement”) is made as of 26th of September 2024 by and between: CanPoland Spółka Akcyjna a POLISH Company having its principal place of business located at ul. Beskidzka 190, 91-610 Łódź, POLAND (NIP:728-283-84-84) (“Buyer”) AND Allied Colombia S.A.S , a Colombian Corporation, having its principal place of business located at Carrera 49

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2024 (September 26, 2024) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Com

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 24, 2024 (September 24, 2024) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (C

ALLIED CORP RELEASES FIRST CERTIFIED GMP MEDICAL CANNABIS PRODUCT IN THE SWISS MARKET

EXHIBIT 99.1 September 24, 2024 NEWS RELEASE OTCQB: ALID 200 – 460 Doyle Avenue, Kelowna, BC, V1Y OC2, Canada Toll Free: 1-250-878-8054 www.allied.health ALLIED CORP RELEASES FIRST CERTIFIED GMP MEDICAL CANNABIS PRODUCT IN THE SWISS MARKET Kelowna, BC, Canada – September 24, 2024 Allied Corp ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has successfully released its firs

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 12, 2024 (August 21, 20

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 12, 2024 (August 21, 2024) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Comm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2024 Commission File Number 000-56002 Allied Corp. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organization) (I

Notification of Late Filing (incorporated by reference to Company's filing on Form NT 10-Q with the Securities and Exchange Commission on July 16, 2024)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 000-56002 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: May 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on For

Allied Corp Successfully Ships 180kgs Of Medical Cannabis Fulfilling Purchase Order, Buyer Granted Additional Import Permits

EXHIBIT 99.1 May 29, 2024 NEWS RELEASE OTCQB: ALID Suite 200 – 460 Doyle Ave Kelowna, BC, Canada V1Y 2E9 Toll Free: 1-877-255-4337 Allied Corp Successfully Ships 180kgs Of Medical Cannabis Fulfilling Purchase Order, Buyer Granted Additional Import Permits Kelowna, BC, Canada – May 29 2024 Allied Corp ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has successfully complete

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2024 (May 29, 2024) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commission Fi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 29, 2024 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organizatio

Notification of Late Filing (incorporated by reference to Company's filing on Form NT 10-Q with the Securities and Exchange Commission on April 15, 2024)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: February 29, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2024 (March 20, 2024) ALLIED CORP. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commissio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2023 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organizatio

Interim Operating Agreement dated September 1, 2023 (incorporated by reference to Exhibit 10.51 of the Company's filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2023)

EXHIBIT 10.51 INTERIM OPERATING AGREEMENT OF ALLIED CORP. a Nevada corporation This Interim Operating Agreement (the “Agreement”) of Allied Corp., a Nevada corporation (the “Company”), is effective as of September 1, 2023 (the “Effective Date”), is entered into by and between the Company and Michael Moses (“Moses). RECITALS A. The Parties hereto have determined that the continued operations of the

Consulting Agreement with Michael Moses (incorporated by reference to Exhibit 10.52 of the Company's filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2023)

EXHIBIT 10.52 CONSULTING AGREEMENT This CONSULTING AGREEMENT (hereafter the "Agreement"), dated as of 2023 (hereafter the “Agreement Date”) and is effective (hereafter the "Effective Date") on receipt of this executed Consulting Agreement delivered by Michael Moses (“Executive”) pursuant to Paragraph 2.5 set out in that certain Interim Operating Agreement of even date herewith (the “Operating Agre

List of Subsidiaries.

EXHIBIT 21 Subsidiaries of Allied Corp. AM (Advanced Micro) Biosciences, Inc. Allied Colombia S.A.S. Allied US Products, LLC Tactical Relief, LLC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the fiscal year ended August 31, 2023 000-56002 (Commission file number) Allied Corp. (Exact name of registrant as specified in its charter) Nevada 33-12271

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2023 (August 31, 2023) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commis

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2023 (November 3, 2023) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commi

SOL NDA Forward Purchase Agreement dated February 8, 2023. (incorporated by reference to Exhibit 10.1 of the Company’s filing on Form 8-K filed with the Securities and Exchange Commission on December 5, 2023)

EXHIBIT 10.1 Forward Purchase Agreement This Agreement (the “Agreement”) is made as of 02/08/2023 by and between: SOL DNA STH PACIFIC PTY LTD, ACN 665 263 025; an Australian Company. 155 The Entrance Rd Erina NSW 2250 Australia. (“Buyer”) AND Allied Colombia S.A.S , a Colombian Corporation, having its principal place of business located at Carrera 49 # 54 73 Barrio Pan de Azucar, Bucaramanga, Colo

One Life Labs Pty Ldt Forward Purchase Agreement dated November 13, 2023. (incorporated by reference to Exhibit 10.2 of the Company’s filing on Form 8-K filed with the Securities and Exchange Commission on December 5, 2023)

EXHIBIT 10.2 Forward Purchase Agreement This Forward Purchase Agreement (the “Agreement”) is made as of 13 November 2023 by and between: OneLife Labs Pty Ltd, an Australian Corporation (ABN 39 616 895 606) have its principal place of business located at Wonthaggi, Victoria, Australia. (“Buyer”) AND Allied Colombia S.A.S , a Colombian Corporation, having its principal place of business located at C

Term Sheet for Contract Manufacturing Services with Blossom Genetics Unipessoal Lda dated October 27, 2023. (incorporated by reference to Exhibit 10.1 of the Company’s filing on Form 8-K filed with the Securities and Exchange Commission on December 5, 2023)

EXHIBIT 10.1 Strictly Private & Confidential TERM SHEET FOR CONTRACT MANUFACTURING SERVICES BETWEEN BLOSSOM AND ALLIED CORP 27 October 2023 1. Parties Allied Corp Headquarters: 1405 St. Paul Street, #201, Kelowna, BC V1Y 2E4 Canada Contacts: Michael Moses [email protected] Or Allied Colombia S.A.S Headquarters: Carrera 49 # 54 73 Barrio Pan de Azucar, Bucaramanga, Colombia Contacts: Benjamin R

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2023 (November 9, 2023) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commi

Australian Cannabis Group Forward Purchase Agreement dated May 30, 2023. (incorporated by reference to Exhibit 10.3 of the Company’s filing on Form 8-K filed with the Securities and Exchange Commission on December 5, 2023)

EXHIBIT 10.3 Forward Purchase Agreement This Agreement (the “Agreement”) is made as of 5/30/2023 by and between: The Australian Cannabis Group, an Australian Corporation, having its principal place of business located at 283 Rokeby Rd, Subiaco WA 6008 (“Buyer”) AND Allied Colombia S.A.S , a Colombian Corporation, having its principal place of business located at Carrera 49 # 54 73 Barrio Pan de Az

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: August 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Fo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2023 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organization) (I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: May 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2023 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organizatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: February 28, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on

Corporate Securities Law

M. Richard Cutler, Esq Corporate Securities Law Admitted in California & Texas February 14, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Division of Corporate Finance Washington, DC 20549 Attn: Scott Stringer and Adam Phippen Re: Allied Corp. Form 10-K for the Fiscal Year Ended August 31, 2022 Filed December 14, 2022 File No. 000-56002 Gentlemen: As you are aware we represent Allied Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 FORM 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 FORM 10-Q/A ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2022 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 FORM 10-K/A (Mark One)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 FORM 10-K/A (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the fiscal year ended August 31, 2022 000-56002 (Commission file number) Allied Corp. (Exact name of registrant as specified in its charte

CUTLER LAW GROUP

CUTLER LAW GROUP M. Richard Cutler, Esq Corporate Securities Law Admitted in California & Texas February 8, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Division of Corporate Finance Washington, DC 20549 Attn: Scott Stringer and Adam Phippen Re: Allied Corp. Form 10-K for the Fiscal Year Ended August 31, 2022 Filed December 14, 2022 File No. 000-56002 Gentlemen: As you are aware we repres

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 FORM 10-K/A (Mark One)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 FORM 10-K/A (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the fiscal year ended August 31, 2022 000-56002 A(Commission file number) Allied Corp. (Exact name of registrant as specified in its chart

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2022 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organizatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: November 30, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on

Convertible Promissory Note issued to Mulsane Ltd. on June 16, 2022 (incorporated by reference to Exhibit 10.49 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022).

EX-10.49 15 alidex1049.htm CONVERTIBLE PROMISSORY NOTE EXHIBIT 10.49 EXECUTION VERSION THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE AND IS SUBJECT TO RESTRICTIONS ON TRANSFER AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND THE APPLICABLE STATE SECURIT

Convertible Promissory Note issued to Tulip Enterprises LLC on January 11, 2022 (incorporated by reference to Exhibit 10.46 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022).

EX-10.46 12 alidex1046.htm CONVERTIBLE PROMISSORY NOTE EXHIBIT 10.46 CONVERTIBLE PROMISSORY NOTE January 11, 2022 PRINCIPAL AMOUNT: USD$150,000.00 DUE: July 10, 2022 FOR VALUE RECEIVED, the undersigned Allied Corp. (the “Borrower” or the “Company”), company incorporated under the laws of the State of Nevada, hereby promises to pay Tulip Enterprises Ltd. (the “Lender”), at such address or at such o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the fiscal year ended August 31, 2022 000-56002 (Commission file number) Allied Corp. (Exact name of registrant as specified in its charter) Nevada 33-12271

Convertible Promissory Note issued to Tulip Enterprises LLC on January 31, 2022 (incorporated by reference to Exhibit 10.47 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022).

EXHIBIT 10.47 CONVERTIBLE PROMISSORY NOTE January 31, 2022 PRINCIPAL AMOUNT: USD$100,000.00 DUE: July 31, 2022 FOR VALUE RECEIVED, the undersigned Allied Corp. (the ?Borrower? or the ?Company?), company incorporated under the laws of the State of Nevada, hereby promises to pay Tulip Enterprises Ltd. (the ?Lender?), at such address or at such other place as the Lender may from time to time designat

List of Subsidiaries. (incorporated by reference to Exhibit 21 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022)

EXHIBIT 21 Subsidiaries of Allied Corp. AM (Advanced Micro) Biosciences, Inc. Allied Colombia S.A.S. Allied US Products, LLC Tactical Relief, LLC.

Convertible Promissory Note issued to Tulip Enterprises LLC on April 21, 2021 (incorporated by reference to Exhibit 10.38 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022).

EXHIBIT 10.38 CONVERTIBLE PROMISSORY NOTE April 29, 2021 PRINCIPAL AMOUNT: USD$180,000.00 DUE: October 29, 2021 FOR VALUE RECEIVED, the undersigned Allied Corp. (the "Borrower" or the ?Company?), company incorporated under the laws of the State of Nevada, hereby promises to pay Tulip Enterprises Ltd. (the "Lender"), at such address or at such other place as the Lender may from time to time designa

Convertible Promissory Note issued to Tulip Enterprises LLC on December 23, 2021 (incorporated by reference to Exhibit 10.44 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022).

EXHIBIT 10.44 CONVERTIBLE PROMISSORY NOTE December 23, 2021 PRINCIPAL AMOUNT: USD$100,000.00 DUE: June 23, 2022 FOR VALUE RECEIVED, the undersigned Allied Corp. (the ?Borrower? or the ?Company?), company incorporated under the laws of the State of Nevada, hereby promises to pay Tulip Enterprises Ltd. (the ?Lender?), at such address or at such other place as the Lender may from time to time designa

Convertible Promissory Note issued to Tulip Enterprises LLC on October 25, 2021 (incorporated by reference to Exhibit 10.43 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022).

EXHIBIT 10.43 CONVERTIBLE PROMISSORY NOTE October 25, 2021 PRINCIPAL AMOUNT: USD$100,000.00 DUE: April 1, 2022 FOR VALUE RECEIVED, the undersigned Allied Corp. (the ?Borrower? or the ?Company?), company incorporated under the laws of the State of Nevada, hereby promises to pay Tulip Enterprises Ltd. (the ?Lender?), at such address or at such other place as the Lender may from time to time designat

Form of Amendment for all outstanding convertible promissory notes September 30, 2022 (incorporated by reference to Exhibit 10.50 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022).

EXHIBIT 10.50 Convertible Promissory Note Amendment and Extension This AMENDMENT (?Amendment?) made as of the 30th day of September 2022, is to that certain CONVERTIBLE PROMISSORY NOTE (hereinafter referred to as the Original Note) made on the th day of , 202 by and between Allied Corp. (?Allied?) and (?Payee?). In consideration of the mutual promises and covenants hereinafter stipulated, the part

Convertible Promissory Note issued to Tulip Enterprises LLC on March 26, 2021 (incorporated by reference to Exhibit 10.37 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022).

EX-10.37 3 alidex1037.htm CONVERTIBLE PROMISSORY NOTE EXHIBIT 10.37 CONVERTIBLE PROMISSORY NOTE March 26, 2021 PRINCIPAL AMOUNT: USD$100,000.00 DUE: September 26, 2021 FOR VALUE RECEIVED, the undersigned Allied Corp. (the "Borrower" or the “Company”), company incorporated under the laws of the State of Nevada, hereby promises to pay Tulip Enterprises Ltd. (the "Lender"), at such address or at such

Convertible Promissory Note issued to Stephen Moses on July 25, 2021 (incorporated by reference to Exhibit 10.41 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022).

EXHIBIT 10.41 CONVERTIBLE PROMISSORY NOTE July 25, 2021 PRINCIPAL AMOUNT: USD$15,000.00 DUE: January 25, 2022 FOR VALUE RECEIVED, the undersigned Allied Corp. (the ?Borrower? or the ?Company?), company incorporated under the laws of the State of Nevada, hereby promises to pay Stephen Moses. (the ?Lender?), at such address or at such other place as the Lender may from time to time designate by writ

Convertible Promissory Note issued to Stephen Moses on March 26, 2021 (incorporated by reference to Exhibit 10.36 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022).

EX-10.36 2 alidex1036.htm CONVERTIBLE PROMISSORY NOTE EXHIBIT 10.36 CONVERTIBLE PROMISSORY NOTE March 26, 2021 PRINCIPAL AMOUNT: USD$18,000.00 DUE: September 26, 2021 FOR VALUE RECEIVED, the undersigned Allied Corp. (the "Borrower" or the “Company”), company incorporated under the laws of the State of Nevada, hereby promises to pay Stephen Moses. (the "Lender"), at such address or at such other pl

Convertible Promissory Note issued to Tulip Enterprises LLC on July 25, 2021 (incorporated by reference to Exhibit 10.40 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022).

EX-10.40 6 alidex1040.htm CONVERTIBLE PROMISSORY NOTE EXHIBIT 10.40 CONVERTIBLE PROMISSORY NOTE July 25, 2021 PRINCIPAL AMOUNT: USD$35,000.00 DUE: January 25, 2022 FOR VALUE RECEIVED, the undersigned Allied Corp. (the “Borrower” or the “Company”), company incorporated under the laws of the State of Nevada, hereby promises to pay Tulip Enterprises Ltd. (the “Lender”), at such address or at such oth

Convertible Promissory Note issued to Stephen Moses on December 23, 2021 (incorporated by reference to Exhibit 10.45 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022).

EXHIBIT 10.45 CONVERTIBLE PROMISSORY NOTE December 23, 2021 PRINCIPAL AMOUNT: USD$100,000.00 DUE: June 23, 2022 FOR VALUE RECEIVED, the undersigned Allied Corp. (the ?Borrower? or the ?Company?), company incorporated under the laws of the State of Nevada, hereby promises to pay Stephen Moses (the ?Lender?), at such address or at such other place as the Lender may from time to time designate by wri

Convertible Promissory Note issued to Stephen Moses on April 30, 2021 (incorporated by reference to Exhibit 10.39 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022).

EX-10.39 5 alidex1039.htm CONVERTIBLE PROMISSORY NOTE EXHIBIT 10.39 CONVERTIBLE PROMISSORY NOTE April 30, 2021 PRINCIPAL AMOUNT: USD$100,000.00 DUE: October 30, 2021 FOR VALUE RECEIVED, the undersigned Allied Corp. (the “Borrower” or the “Company”), company incorporated under the laws of the State of Nevada, hereby promises to pay Stephen Moses. (the “Lender”), at such address or at such other pla

Convertible Promissory Note issued to 0994091 BC Ltd. on March 29, 2022 (incorporated by reference to Exhibit 10.48 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022).

EXHIBIT 10.48 CONVERTIBLE PROMISSORY NOTE March 29, 2022 PRINCIPAL AMOUNT: USD$500,000.00 DUE: September 30, 2022 FOR VALUE RECEIVED, the undersigned Allied Corp. (the ?Borrower? or the ?Company?), company incorporated under the laws of the State of Nevada, hereby promises to pay 0994091 BC Ltd (the ?Lender?), at such address or at such other place as the Lender may from time to time designate by

Convertible Promissory Note issued to Tulip Enterprises LLC on October 1, 2021 (incorporated by reference to Exhibit 10.42 of the Company’s filing on Form 10-K filed with the Securities and Exchange Commission on December 14, 2022).

EXHIBIT 10.42 CONVERTIBLE PROMISSORY NOTE October 1, 2021 PRINCIPAL AMOUNT: USD$100,000.00 DUE: April 1, 2022 FOR VALUE RECEIVED, the undersigned Allied Corp. (the ?Borrower? or the ?Company?), company incorporated under the laws of the State of Nevada, hereby promises to pay Tulip Enterprises Ltd. (the ?Lender?), at such address or at such other place as the Lender may from time to time designate

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: August 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Fo

Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2022 (July 20, 2022) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2022 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organization) (I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: May 31, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form

Press Release dated April 28, 2022

EXHIBIT 10.2 April 27, 2022 NEWS RELEASE OTCQB: ALID Suite 201 ? 1405 St. Paul Street Kelowna, BC, Canada V1Y 2E9 Toll Free: 1-877-255-4337 www.allied.health ALLIED CORP ANNOUNCES INITIAL US$147,000 PURCHASE ORDER CONTINUING INTO MONTHLY SUPPLY AGREEMENT FOR BRAZILIAN SPECIALTY CANCER CARE HOSPITAL Kelowna, BC, Canada ? April 27, 2022 Allied Corp. ("Allied" or the ?Company?) (OTCQB: ALID) is pleas

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2022 (April 28, 2022) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commissio

Forward Purchase Agreement between CPHARMACEUTICA DISTRIBUIDORA DE PRODUTOS MEDICOS LTDA and Allied Corp dated as of April 28, 2022.

EXHIBIT 10.1 Forward Purchase Agreement Contrato de Compra e Venda This Agreement (the ?Agreement?) is made as of 4/26/2022 by and between: CPHARMACEUTICA DISTRIBUIDORA DE PRODUTOS MEDICOS LTDA STREET: MATO GROSSO 219 SALA 204 - BARRO PRETO - BELO HORIZONTE - MINAS GERAIS- BRASIL CEP 30.190-081 (?Buyer?) AND Allied Corp 112 North Curry Street, Carson City, NV 89703. Principal Executive Offices: 14

ALLIED CORP. 1405 St. Paul St., Suite 201, Kelowna, BC, Canada V1Y 9N2 April 28, 2022

ALLIED CORP. 1405 St. Paul St., Suite 201, Kelowna, BC, Canada V1Y 9N2 April 28, 2022 Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Re: Allied Corp. Offering Circular on Form 1-A File No. 024-11855 Acceleration Request Requested Date: May 3, 2022, 11:00 am Eastern Standard Time Gentlemen and Ladies: Pursuant to Rule 461 under the Securi

CUTLER LAW GROUP

EXHIBIT 12 CUTLER LAW GROUP Corporate Securities Law M. Richard Cutler, Esq Admitted in California & Texas April 22, 2022 Allied Corp. 1405 St. Paul St., Suite 201 Kelowna, BC, Canada V1Y 9N2 Re: Allied Corp. Gentlemen and Ladies: Re: Opinion of Counsel - Registration Statement on Form 1-A We have acted as counsel to you in connection with your filing of an offering statement on Form 1-A filed Apr

Consent of Independent Registered Public Accounting Firm

EXHIBIT 11.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Offering Statement on Form 1-A Amendment No. 1 of our report dated December 14, 2021, relating to the consolidated financial statements of Allied Corp. appearing in the Annual Report on Form 10-K of Allied Corp. for the year ended August 31, 2021, and incorporated by reference

PART II AND PART III - OFFERING CIRCULAR DATED April 22, 2022

PART II AND PART III - OFFERING CIRCULAR DATED April 22, 2022 File No. 024-11855 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 FORM 1-A Parts II & III PART II - OFFERING CIRCULAR ALLIED CORP. 1405 St. Paul St., Suite 201, Kelowna, BC, Canada V1Y 9N2 Telephone: 877-255-4337 www.allied.health With a copy to: M. Richard Cutler, Esq. Cutler Law Group 6575 West

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2022 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organizatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: February 28, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on

Consent of Independent Registered Public Accounting Firm

EXHIBI|T 11.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Offering Statement on Form 1-A of our report dated December 14, 2021, relating to the consolidated financial statements of Allied Corp. appearing in the Annual Report on Form 10-K of Allied Corp. for the year ended August 31, 2021, and incorporated by reference to this Regist

PART II AND PART III - PRELIMINARY OFFERING CIRCULAR DATED ______________, 2022 SUBJECT TO COMPLETION

PART II AND PART III - PRELIMINARY OFFERING CIRCULAR DATED , 2022 SUBJECT TO COMPLETION File No.

CUTLER LAW GROUP

EXHIBIT 12 CUTLER LAW GROUP Corporate Securities Law M. Richard Cutler, Esq Admitted in California & Texas April 6, 2022 Allied Corp. 1405 St. Paul St., Suite 201 Kelowna, BC, Canada V1Y 9N2 Re: Allied Corp. Gentlemen and Ladies: Re: Opinion of Counsel - Registration Statement on Form 1-A We have acted as counsel to you in connection with your filing of an offering statement on Form 1-A filed Apri

SUBSCRIPTION AGREEMENT AND INVESTOR QUESTIONNAIRE Allied Corp., a Nevada corporation

EXHIBIT 4 SUBSCRIPTION AGREEMENT AND INVESTOR QUESTIONNAIRE Allied Corp., a Nevada corporation Please carefully read all instructions and the terms and conditions of your Private Placement Memorandum dated April 5, 2022 (as amended or supplemented, the “Memorandum”) before filling out this Subscription Agreement and Investor Questionnaire (the “Subscription Agreement”). The Subscription Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2021 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2021 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organizatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 000-56002

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 000-56002 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: November 30, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the fiscal year ended August 31, 2021 000-56002 (Commission file number) Allied Corp. (Exact name of registrant as specified in its charter) Nevada 33-12271

List of Subsidiaries.

EXHIBIT 21 Subsidiaries of Allied Corp. AM (Advanced Micro) Biosciences, Inc. Allied Colombia S.A.S. Pacific Sun Fungi Inc. Allied US Products, LLC Tactical Relief, LLC.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2021 (December 2, 2021) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 000-56002 33-1227173 (State or Other Jurisdiction of Incorporation) (Com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 000-56002

NT 10-K 1 alidnt10k.htm NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 000-56002 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: August 31, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on F

Allied Corp. 1405 St. Paul St., Suite 201 Kelowna, BC, Canada V1Y 9N2

1-A-W 1 alid1aw.htm 1-A-W Allied Corp. 1405 St. Paul St., Suite 201 Kelowna, BC, Canada V1Y 9N2 By EDGAR October 14, 2021 United States Securities and Exchange Commission Division of Corporate Finance 100 F Street NE, Mail Stop 3561 Washington, D.C. 20549 Re: Offering Circular on Form 1-A (File No. 024-115500) Application for Withdrawal To Whom It May Concern: Pursuant to Rule 259(a) of the Securi

Consent of Independent Registered Public Accounting Firm

EXHIBIT 11.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Amendment No.1 to Offering Statement on Form 1-A (“Amendment No.1”) of our report dated December 15, 2020, relating to the consolidated financial statements of Allied Corp. appearing in the Annual Report on Form 10-K of Allied Corp. for the year ended August 31, 2020, and inco

PART II AND PART III -PRELIMINARY OFFERING CIRCULAR DATED AUGUST 20, 2021 SUBJECT TO COMPLETION

PART II AND PART III -PRELIMINARY OFFERING CIRCULAR DATED AUGUST 20, 2021 SUBJECT TO COMPLETION File No.

CONFIDENTIAL

EXHIBIT 1.1 CONFIDENTIAL May 7, 2021 Calum Hughes Chief Executive Officer and Director Allied Corp. 1405 St. Paul St., Suite 201 Kelowna, British Columbia, Canada VIY 9N2 Re: Proposed Pre-IPO, Initial Public Offering, and Corporate Finance Transactions Dear Mr. Hughes: Boustead Securities, LLC together with its subsidiaries and affiliates (collectively, ?Boustead?), is pleased to submit the follow

Amendment No. 1 to Placement Agent Agreement between the Company and Boustead Securities, LLC dated as of August 17, 2021 (incorporated by reference to Exhibit 3.2 of the Company’s filing on Form 1-A filed with the Securities and Exchange Commission on August 23, 2021)

EXHIBIT 1.2 AMENDMENT NO. 1 TO PLACEMENT AGENT AGREEMENT THIS AMENDMENT NO. 1 TO PLACEMENT AGENT AGREEMENT (this ?Amendment No. 1?), is made and entered into as of August 17, 2021 (the ?Effective Date?), by and among Allied Corp. (the ?Company?); and Boustead Securities, LLC (?BSL?). The Company and BSL may be referred to herein collectively as the ?Parties? or singularly as a ?Party.? BSL and the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2021 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organization) (I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 000-56002

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 000-56002 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: May 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on For

Placement Agent Agreement between the Company and Boustead Securities, LLC dated as of May 7, 2021 (incorporated by reference to Exhibit 3.1 of the Company’s filing on Form 1-A filed with the Securities and Exchange Commission on August 23, 2021)

EXHIBIT 1.1 CONFIDENTIAL Date: June , 2021 To: Allied Corp. 1405 St. Paul St., Suite 201 Kelowna, BC, Canada V1Y 9N2 Attn: Calum Hughes, Chief Executive Officer Re: Proposed Financing, IPO and Corporate Finance Transactions Dear Mr. Hughes: We are pleased to submit the following letter agreement with respect to one or more planned financings or U.S. initial public offerings by and for Allied Corp.

PART II AND PART III -PRELIMINARY OFFERING CIRCULAR DATED JUNE 11, 2021 SUBJECT TO COMPLETION

PART II AND III 2 alid1a.htm FORM 1-A PART II AND PART III -PRELIMINARY OFFERING CIRCULAR DATED JUNE 11, 2021 SUBJECT TO COMPLETION File No. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1-A Parts II & III PART II - OFFERING CIRCULAR ALLIED CORP. 1405 St. Paul St., Suite 201, Kelowna, BC, Canada V1Y 9N2 Telephone: 877-255-4337 www.allied.health With a copy to: M. Ric

Form of Participating Dealers Agreement BOUSTEAD SECURITIES, LLC 6 Venture, Suite 325 Irvine, CA 92618 949-295-1580 PARTICIPATING DEALER AGREEMENT for Shares in Allied Corp. _______ , 2021

EX1A-1 UNDR AGMT.2 4 alidex12.htm SELECTED DEALERS AGREEMENT EXHIBIT 1.2 Form of Participating Dealers Agreement BOUSTEAD SECURITIES, LLC 6 Venture, Suite 325 Irvine, CA 92618 949-295-1580 PARTICIPATING DEALER AGREEMENT for Shares in Allied Corp. , 2021 Ladies and Gentlemen: The undersigned, Boustead Securities, LLC, a California limited liability company (the “Managing Broker-Dealer”), has entere

Consent of Independent Registered Public Accounting Firm

EXHIBIT 11.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Offering Statement on Form 1-A of our report dated December 15, 2020, relating to the consolidated financial statements of Allied Corp. appearing in the Annual Report on Form 10-K of Allied Corp. for the year ended August 31, 2020, and incorporated by reference to this Registr

CUTLER LAW GROUP

EX1A-12 OPN CNSL 9 alidex121.htm OPINION CUTLER LAW GROUP M. Richard Cutler, Esq Corporate Securities Law Admitted in California & Texas June 11, 2021 Allied Corp. 1405 St. Paul St., Suite 201 Kelowna, BC, Canada V1Y 9N2 Re: Allied Corp. Gentlemen and Ladies: Re: Opinion of Counsel - Registration Statement on Form 1-A We have acted as counsel to you in connection with your filing of an offering st

OPTION TO PURCHASE ASSET AGREEMENT

EXHIBIT 6.35 OPTION TO PURCHASE ASSET AGREEMENT This Option to Purchase Asset Agreement (this “Agreement”), effective as of April 30, 2021 but executed on May 11, 2021 (the “Execution Date”, is entered into between Marapharm Las Vegas LLC, a Nevada limited liability company (“Seller”), and Allied US Products, LLC, a Nevada limited liability company (“Buyer”). RECITALS WHEREAS, Buyer is a research

Form of Underwriter Warrant (incorporated by reference to Exhibit 3.1 of the Company’s Offering Statement filing on Form 1-A filed with the Securities and Exchange Commission on June 11, 2021)

EX1A-3 HLDRS RTS.1 5 alidex31.htm UNDERWRITER WARRANT EXHIBIT 3.1 Form of Boustead Warrant Agreement THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES BY HIS, HER OR ITS ACCEPTANCE HEREOF, THAT SUCH HOLDER WILL NOT FOR A PERIOD OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING THE QUALIFICATION DATE (AS DEFINED BELOW) OF THE OFFERING STATEMENT: (A) SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS P

PROMISSORY NOTE

EXHIBIT 6.36 PROMISSORY NOTE $1,350,000.00 May 11, 2021 Las Vegas, Nevada FOR VALUE RECEIVED, the undersigned, Allied Corp., a Nevada corporation (“Debtor”), hereby promises to pay to Marapharm Las Vegas LLC, a Nevada limited liability company (“Holder”), or its successors or permitted assigns, in lawful currency of the United States of America, the aggregate principal sum of One Million Three Hun

- NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: February 28, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2021 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organizatio

Services Agreement dated as of March 30, 2021 between Marapharm Las Vegas LLC and Allied US Products LLC.

EXHIBIT 10.4 SERVICES AGREEMENT This Services Agreement (this ?Agreement?), dated as of March 30, 2021 (the ?Execution Date?), is entered into by and between Marapharm Las Vegas LLC, a Nevada limited liability company with a place of business at 102-1561 Sutherland Ave., Kelowna, British Columbia, Canada V1Y 5Y7 (?Service Provider?), and Allied US Products, LLC, a Nevada limited liability company

Land Lease dated as of March 30, 2021 between Marapharm Las Vegas LLC and Tactical Relief LLC.

EXHIBIT 10.1 LAND LEASE THIS LAND LEASE (this ?Lease?) is entered into as of the 30th day of March, 2021 (?Effective Date?), between MARAPHARM LAS VEGAS LLC, a Nevada limited liability company with a place of business at 102-1561 Sutherland Ave., Kelowna, BC Canada V1Y 5Y7 (?Marapharm?), and TACTICAL RELIEF, LLC, a Delaware limited liability company with a place business at 201 ? 1405 St Paul St.,

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 7, 2021 (March 30, 2021) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commission

Asset Purchase Agreement dated as of March 30, 2021 between Marapharm Las Vegas LLC and Allied US Products, LLC.

EXHIBIT 10.2 ASSET PURCHASE AGREEMENT This Asset Purchase Agreement (this ?Agreement?), dated as of March 30, 2021 (the ?Execution Date?, is entered into between Marapharm Las Vegas LLC, a Nevada limited liability company (?Seller?), and Allied US Products, LLC, a Nevada limited liability company (?Buyer?). RECITALS WHEREAS, Buyer is a research and development company, focused on creating and prov

Promissory Note dated as of March 30, 2021 from Allied US Products LLC in favor of Marapharm Las Vegas LLC.

EXHIBIT 10.3 PROMISSORY NOTE $1,350,000.00 March 30, 2021 Las Vegas, Nevada FOR VALUE RECEIVED, the undersigned, Allied Corp., a Nevada corporation (?Debtor?), hereby promises to pay to Marapharm Las Vegas LLC, a Nevada limited liability company (?Holder?), or its successors or permitted assigns, in lawful currency of the United States of America, the aggregate principal sum of One Million Three H

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2020 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organizatio

- NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: November 30, 2020 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on

Annual Report - FORM 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the fiscal year ended August 31, 2020 0-27675 (Commission file number) Allied Corp. (Exact name of registrant as specified in its charter) N

List of Subsidiaries.

EXHIBIT 21 Subsidiaries of Allied Corp. AM (Advanced Micro) Biosciences, Inc. Allied Colombia S.A.S.

Annual Report - FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the fiscal year ended August 31, 2020 0-27675 (Commission file number) Allied Corp. (Exact name of registrant as specified in its charter) Nevada 33-1227173

Series A Warrant issued to CA Indosuez (Switzerland) S.A. January 23, 2020 (incorporated by reference to Exhibit 10.11 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.11 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISEABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FO

Convertible Promissory Note issued to Sawasawa Inc. September 30, 2020 (incorporated by reference to Exhibit 10.32 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.32 CONVERTIBLE PROMISSORY NOTE September 29, 2020 PRINCIPAL AMOUNT: USD$163,341.25 DUE: April 1, 2020 FOR VALUE RECEIVED, the undersigned Allied Corp. (the "Borrower" or the “Company”), company incorporated under the laws of the State of Nevada, hereby promises to pay Sawasawa Limited (the "Lender"), at such address or at such other place as the Lender may from time to time designate by

Convertible Promissory Note issued to Sawasawa Inc. November 7, 2020 (incorporated by reference to Exhibit 10.33 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on December 16, 2020)

EXHIBIT 10.33 CONVERTIBLE PROMISSORY NOTE October 26, 2020 PRINCIPAL AMOUNT: USD$37,613.17 DUE: April 23, 2020 FOR VALUE RECEIVED, the undersigned Allied Corp. (the "Borrower" or the “Company”), company incorporated under the laws of the State of Nevada, hereby promises to pay Sawasawa Limited (the "Lender"), at such address or at such other place as the Lender may from time to time designate by w

2020 Long term Incentive Plan (incorporated by reference to Exhibit 10.21 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.21 ALLIED CORP. 2020 LONG-TERM INCENTIVE PLAN SECTION 1 PURPOSE The purpose of the Allied Corp. 2020 Long-Term Incentive Plan is to align the interests of employees of the Corporation selected to receive awards with those of stockholders by rewarding long term decision-making and actions for the betterment of the Corporation. Accordingly, Eligible Individuals may receive Awards of Optio

Series A Warrant issued to Allied Special Opportunities Limited February 25, 2020 (incorporated by reference to Exhibit 10.17 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.17 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISEABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FO

Security Agreement dated as of January 23, 2020 between the Company and CA Indosuez (Switzerland) S.A. (incorporated by reference to Exhibit 10.12 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.12 SECURITY AGREEMENT BY ALLIED CORP. IN FAVOR OF CA INDOSUEZ (SWITZERLAND) SA January 23, 2020 TABLE OF CONTENTS Page ARTICLE I GENERAL TERMS 1 1.1 Terms Defined Above 1 1.2 Definitions Contained in Subscription Agreement 1 1.3 Certain Definitions 1 1.4 Terms Defined in Code 2 ARTICLE II SECURITY INTEREST 2 ARTICLE III REPRESENTATIONS AND WARRANTIES 4 4 3.1 Ownership and Liens 3 3.2 St

Convertible Promissory Note issued to Parkward Holding Ltd. January 23, 2020 (incorporated by reference to Exhibit 10.13 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.13 CONVERTIBLE PROMISSORY NOTE January 23, 2020 PRINCIPAL AMOUNT: USD$400,000 DUE: July 20, 2020 FOR VALUE RECEIVED, the undersigned Allied Corp. (the "Borrower" or the “Company”), company incorporated under the laws of the State of Nevada, hereby promises to pay PARKWARD HOLDING LTD. (the "Lender"), at such address or at such other place as the Lender may from time to time designate by

Settlement and Release Agreement between the Company and David Weinkauf dated September 21, 2020 (incorporated by reference to Exhibit 10.30 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.30

Settlement and Release Agreement between the Company and Anthony Zelen dated September 17, 2020 (incorporated by reference to Exhibit 10.29 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.29

Convertible Promissory Note issued to Allied Special Opportunities Limited February 25, 2020 (incorporated by reference to Exhibit 10.16 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.16 CONVERTIBLE PROMISSORY NOTE February , 2020 PRINCIPAL AMOUNT: USD$1,300,000 DUE: August , 2020 FOR VALUE RECEIVED, the undersigned Allied Corp. (the "Borrower" or the “Company”), company incorporated under the laws of the State of Nevada, hereby promises to pay Allied Special Opportunities Limited (the "Lender"), at such address or at such other place as the Lender may from time to t

Convertible Promissory Note issued to CA Indosuez (Switzerland) S.A. January 23, 2020 (incorporated by reference to Exhibit 10.10 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.10 CONVERTIBLE PROMISSORY NOTE January 23, 2020 PRINCIPAL AMOUNT: USD$200,000 DUE: July 20, 2020 FOR VALUE RECEIVED, the undersigned Allied Corp. (the "Borrower" or the “Company”), company incorporated under the laws of the State of Nevada, hereby promises to pay CA INDOSUEZ (SWITZERLAND) SA (the "Lender"), at such address or at such other place as the Lender may from time to time desig

Settlement and Release Agreement between the Company and Malcolm Davidson dated September 16, 2020 (incorporated by reference to Exhibit 10.31 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.31

Security Agreement dated as of January 23, 2020 between the Company and Allied Special Opportunities Lit.. (incorporated by reference to Exhibit 10.18 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.18 SECURITY AGREEMENT BY ALLIED CORP. IN FAVOR OF ALLIED SPECIAL OPPORTUNITIES LIMITED February , 2020 TABLE OF CONTENTS Page ARTICLE I GENERAL TERMS 1 1.1 Terms Defined Above 1 1.2 Definitions Contained in Subscription Agreement 1 1.3 Certain Definitions 1 1.4 Terms Defined in Code 2 ARTICLE II SECURITY INTEREST 2 ARTICLE III REPRESENTATIONS AND WARRANTIES 3 3.1 Ownership and Liens 3 3

Security Agreement dated as of January 23, 2020 between the Company and Parkward Holding Ltd. (incorporated by reference to Exhibit 10.15 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.15 SECURITY AGREEMENT BY ALLIED CORP. IN FAVOR OF PARKWARD HOLDING LTD. January 23, 2020 TABLE OF CONTENTS Page ARTICLE I GENERAL TERMS 1 1.1 Terms Defined Above 1 1.2 Definitions Contained in Subscription Agreement 1 1.3 Certain Definitions 1 1.4 Terms Defined in Code 2 ARTICLE II SECURITY INTEREST 2 ARTICLE III REPRESENTATIONS AND WARRANTIES 4 3.1 Ownership and Liens 4 3.2 Status of A

Loan and Security Agreement dated May 14, 2020 between the Company and SLCI1, LLC. (incorporated by reference to Exhibit 10.19 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.19 Loan and security agreement. This Loan and Security Agreement ("Agreement") is made this day of May 2020 between SLCI1, LLC, a Colorado limited liability company ("Lender") and Allied Corp., a Delaware corporation ("Borrower"). In consideration of the loan agreed to be made, the security interest granted, and the other covenants and agreements made by this Agreement, and for other go

Convertible Promissory Note issued to Sawasawa, Inc. November 30, 2020 (incorporated by reference to Exhibit 10.34 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on December 16, 2020)

EXHIBIT 10.34 CONVERTIBLE PROMISSORY NOTE (3) November 11, 2020 PRINCIPAL AMOUNT: USD$85,937.00 DUE: May 20, 2020 FOR VALUE RECEIVED, the undersigned Allied Corp. (the "Borrower" or the “Company”), company incorporated under the laws of the State of Nevada, hereby promises to pay Sawasawa Limited (the "Lender"), at such address or at such other place as the Lender may from time to time designate b

Series A Warrant issued to Parkward Holding Ltd. January 23, 2020 (incorporated by reference to Exhibit 10.14 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.14 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISEABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FO

Promissory Note issued May 14, 2020 from the Company to SLCI1, LLC. (incorporated by reference to Exhibit 10.20 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2020)

EXHIBIT 10.20 PROMISSORY NOTE $1,253,772.30 DATE: May , 2020 (the “Effective Date”) FOR VALUE RECEIVED, Allied Corp. (“Maker”) hereby promises to pay to SLCI, LLC (“Holder”) the principal sum of One Million, Two Hundred Fifty Three Thousand Sevcen Hundred Seventy Two and 30/100 Dollars ($1,253,772.30), plus 36% simple interest per annum. Maker will make monthly payments of interest only for the fi

- NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: August 31, 2020 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Fo

ALID / Allied Corp. / Allied Special Opportunity Ltd - SC 13D Activist Investment

Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13D Under the Securities Exchange Act of 1934 Allied Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 019114107 (CUSIP Number) M. Richard Cutler, Cutler Law Group, PC, 6575 West Loop South, Suite 500, Bellaire, TX 77401 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications

License for Medicolombia Cannabis A.S. from Republic of Columbia, Ministry of Justice and Law, dated February 20, 2019 (incorporated by reference to Exhibit 10.5 of the Company’s Report filing on Form 8-K filed with the Securities and Exchange Commission on October 7, 2020)

EXHIBIT 10.5 Ministry of Justice and Law Republic of Colombia RESOLUTION 0197 OF FEB 20th, 2019 Whereby psychoactive cannabis plant cultivation license is granted THE DEPUTY DIRECTOR OF CONTROL AND SUPERVISION OF CHEMICAL SUBSTANCES AND NARCOTICS OF THE MINISTRY OF JUSTICE AND LAW In exercise of the legal powers, especially those conferred by Law 1787 of 2016, Decrees 1427 and 613 of 2017, in acco

License for Medicolombia Cannabis A.S. from Republic of Columbia, Ministry of Justice and Law, dated August 3, 2018 (incorporated by reference to Exhibit 10.2 of the Company’s Report filing on Form 8-K filed with the Securities and Exchange Commission on October 7, 2020)

EXHIBIT 10.2 Ministry of Justice and Law Republic of Colombia RESOLUTION 0754 OF AUG 3RD 2018 Whereby a License to use seeds for sowing is granted THE DEPUTY DIRECTOR OF CONTROL AND FISCAL MONITORING OF CHEMICALS AND NARCOTICS OF THE MINISTRY OF JUSTICE AND LAW In exercise of the legal powers, especially those conferred by Law 1787 of 2016; Decree 1427 of 2017, Decree 813 of 2017, in accordance wi

Share Purchase Agreement between Dorson Commercial Corp. and AD (Advanced Micro) Biosciences, Inc. dated August 29, 2019 (incorporated by reference to Exhibit 10.1 of the Company’s Report filing on Form 8-K filed with the Securities and Exchange Commission on October 7, 2020)

EXHIBIT 10.1

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2020 (August 29, 2019) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commiss

License for Medicolombia Cannabis A.S. from Republic of Columbia, Ministry of Justice and Law, dated July 31, 2019 (incorporated by reference to Exhibit 10.4 of the Company’s Report filing on Form 8-K filed with the Securities and Exchange Commission on October 7, 2020)

EXHIBIT 10.4 Ministry of Justice and Law Republic of Colombia RESOLUTION 0 8 8 2 OF JULY 31st, 2019 Through which a license for the cultivation of non-psychoactive Cannabis plants is granted THE DEPUTY DIRECTOR OF CONTROL AND SUPERVISION OF CHEMICAL SUBSTANCES AND NARCOTICS OF THE MINISTRY OF JUSTICE AND LAW In the exercise of legal powers, especially those conferred by Law 1787 of 2016, Decrees 1

License for Medicolombia Cannabis A.S. from Republic of Columbia, National Narcotics Fund U.A.E., Ministry of Health and Social Protection dated January 13, 2020 (incorporated by reference to Exhibit 10.8 of the Company’s Report filing on Form 8-K filed with the Securities and Exchange Commission on October 7, 2020)

EXHIBIT 10.8 Republic of Colombia National Narcotics Fund U.A.E. Ministry of Health and Social Protection RESOLUTION NUMBER 009 OF 2020 (JANUARY 13TH 2020) Whereby a modification of an ex officio Registration before the National Narcotics Fund U.A.E. of a license holder manufacturing derivatives of cannabis is made THE DIRECTOR OF THE SPECIAL ADMINISTRATIVE UNIT NATIONAL NARCOTICS FUND In use of i

License for Medicolombia Cannabis A.S. from Republic of Columbia, Ministry of Health and Social Protection, dated November 29, 2019 (incorporated by reference to Exhibit 10.6 of the Company’s Report filing on Form 8-K filed with the Securities and Exchange Commission on October 7, 2020)

EXHIBIT 10.6 MINISTRY OF HEALTH AND SOCIAL PROTECTION RESOLUTION NUMBER 003220 OF 2019 (NOV 29TH 2019 ) Whereby Resolution 5521 of December 4th, 2018 is modified, which granted license for the manufacture of cannabis derivatives to MEDICOLOMBIA'S CANNABIS S.A.S. THE DIRECTOR OF MEDICINES AND HEALTH TECHNOLOGIES In the exercise of his legal powers, in particular those conferred in the article 2.8.1

License for Medicolombia Cannabis A.S. from Republic of Columbia, Ministry of Health and Social Protection, dated December 4, 2018 (incorporated by reference to Exhibit 10.3 of the Company’s Report filing on Form 8-K filed with the Securities and Exchange Commission on October 7, 2020)

EXHIBITS 10.3 REPUBLIC OF COLOMBIA MINISTRY OF HEALTH AND SOCIAL PROTECTION RESOLUTION NUMBER 00005521 OF 2018 ( DEC 4th 2018) Whereby a license for the manufacture of cannabis derivatives is granted to MEDICOLOMBIA'S CANNABIS S.A.S. THE DIRECTOR OF MEDICINES AND HEALTH TECHNOLOGIES In the exercise of his powers, in particular those conferred by Article 3 of Law 30 of 1986, 6 of Law 1787 of 2016,

License for Medicolombia Cannabis A.S. from Republic of Columbia, Minagricultura dated May 05, 2019 (incorporated by reference to Exhibit 10.7 of the Company’s Report filing on Form 8-K filed with the Securities and Exchange Commission on October 7, 2020)

EXHIBIT 10.7 GOVERNMENT OF COLOMBIA MINAGRICULTURA ICA Instituto Colombiano Agropecuario RESOLUTION No. 00005922 (05/05/2019) Whereby the Registration as an Agronomic Evaluation Unit of Psychoactive and non-psychoactive cannabis is granted to MEDICOLOMBIA'S CANNABIS S.A.S., for the Andean natural sub-region, with altitude between 1200 and 1800 mamsl. THE ASSISTANT MANAGER OF PLANT PROTECTION AT TH

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2020 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organization) (I

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 2 TO FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2019 (November 12, 2019) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of

Letter from Marcum LLP

EXHIBIT 16.1 June 24, 2020 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Commissioners: We have read the statements made by Allied Corp. (formerly Cosmo Ventures Inc.) under Item 4.01 of Amendment No. 2 to Form 8-K dated November 15, 2019. We agree with the statements concerning our firm in such Form 8-K; we are not in a position to agree or disagree with other state

Letter from Marcum LLP

EXHIBIT 16.1 June 23, 2020 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Commissioners: We have read the statements made by Allied Corp. (formerly Cosmo Ventures Inc.) under Item 4.01 of Amendment No. 1 to Form 8-K dated November 15, 2019. We agree with the statements concerning our firm in such Form 8-K; we are not in a position to agree or disagree with other state

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2019 (November 12, 2019) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 29, 2020 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organizatio

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2020 (May 20, 2020) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commission Fi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2019 (May 2, 2020) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commission File

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2020 (April 15, 2020) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commissio

ALID / Allied Corp. NT 10-Q - - NT 10-Q

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: February 29, 2020 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 2, 2020 (March 24, 2020) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commission

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2019 (March 18, 2020) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commissio

ALID / Allied Corp. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2019 Commission File Number 000-56002 ALLIED CORP. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organizatio

ALID / Allied Corp. NT 10-Q - - NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: November 30, 2019 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on

Assumption of contract of purchase and sale of 8999 Jim Bailey Rd. between the Company and 1185710 B.C. Ltd. Dated November 6, 2018 (incorporated by reference to Exhibit 10.2 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2019)

EXHIBIT 10.2

Escrow Agreement between AM (Advanced Micro) Biosciences, Inc., and Maryls Wolfe dated May 31, 2019 (incorporated by reference to Exhibit 10.4 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2019)

EXHIBIT 10.4

Certificate of Amendment of Articles of Incorporation dated July 1, 2019 (incorporated by reference to Exhibit 3.3 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2019)

EXHIBIT 3.3

List of Subsidiaries.

EXHIBIT 21 Subsidiaries of Allied Corp. AM (Advanced Micro) Biosciences, Inc. – As of September 10, 2019

Vitalis Extraction Technology Sales Order dated August 30, 2019 (incorporated by reference to Exhibit 10.6 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2019)

EXHIBIT 10.6

Xtreme Cubes - Purchase Proposal dated May 14, 2019 (incorporated by reference to Exhibit 10.5 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2019)

EXHIBIT 10.5

Asset Purchase Agreement between AM (Advanced Micro) Biosciences, Inc. and Clifford Wade Lackie and Robin Dale Lackie for Bud’s Naturals dated February 13, 2019 (incorporated by reference to Exhibit 10.8 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2019)

EXHIBIT 10.8

Purchase Agreement between AM (Advanced Micro) Biosciences, Inc. and 1150641 BC Ltd., doing business as Activated Nano, dated May 22, 2019 (incorporated by reference to Exhibit 10.7 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2019)

EXHIBIT 10.7

ALID / Allied Corp. 10-KT - - FORM 10-KT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ¨ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 x TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from April 1, 2019 to August 31, 2019 0-27675 (Commission file number) Allied Corp. (Exact name of registrant as specified in its char

Consulting Agreement between AM (Advanced Micro) Biosciences, Inc. and John Saric dated May 31, 2019 (incorporated by reference to Exhibit 10.9 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2019)

EXHIBIT 10.9

Share Purchase Agreement between AM (Advanced Micro) Biosciences, Inc. and Maryls Wolfe and Grant Wolfe dated May 24, 2019. (incorporated by reference to Exhibit 10.3 of the Company’s Report filing on Form 10-K filed with the Securities and Exchange Commission on August 31, 2019)

EXHIBIT 10.3

ALID / Allied Corp. NT 10-K - - NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: August 31, 2019 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Fo

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2019 (September 10, 2019) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction o

AM (Advanced Micro) Biosciences, Inc. INDEX TO THE FINANCIAL STATEMENTS

EXHIBIT 99.1 AM (Advanced Micro) Biosciences, Inc. INDEX TO THE FINANCIAL STATEMENTS Report of Independent Registered Public Accounting Firm 2 Balance Sheet at August 31, 2019 3 Statement of Operations and Comprehensive Loss for the period ended August 31, 2019 4 Statement of Stockholders’ Equity for the period ended August 31, 2019 5 Statement of Cash Flows for the period ended August 31, 2019 6

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2019 (November 12, 2019) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Com

Allied Corp. Signs Definitive Distribution Agreement to Sell CBD-Based Cosmetic and Natural Health Products Throughout Asia

EXHIBIT 99.1 Suite 201 – 1405 St. Paul Street Kelowna, BC, Canada V1Y 2E9 Toll Free: 1-877-255-4337 www.allied.health Oct 03, 2019 NEWS RELEASE OTBQB: ALID Allied Corp. Signs Definitive Distribution Agreement to Sell CBD-Based Cosmetic and Natural Health Products Throughout Asia Kelowna, BC, Canada – October 03, 2019 – Allied Corp. (“Allied”) (OTCQB: ALID) – an international medical cannabis compa

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 11, 2019 (October 2, 2019) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (Commis

Distribution Agreement

EXHIBIT 10.1

ALID / Allied Corp. / Zelen Anthony - SC 13G Passive Investment

Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Allied Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 019114 107 (CUSIP Number) M. Richard Cutler, Cutler Law Group, PC, 6575 West Loop South, Suite 500, Bellaire, TX 77401 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communication

ALID / Allied Corp. / Secfac Exchange Corp. - SC 13G Passive Investment

Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Allied Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 019114 107 (CUSIP Number) M. Richard Cutler, Cutler Law Group, PC, 6575 West Loop South, Suite 500, Bellaire, TX 77401 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communication

ALID / Allied Corp. / Hughes Calum - SC 13G Passive Investment

Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Allied Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 019114 107 (CUSIP Number) M. Richard Cutler, Cutler Law Group, PC, 6575 West Loop South, Suite 500, Bellaire, TX 77401 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communication

ALID / Allied Corp. / Bullock Paul James - SC 13G Passive Investment

Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Allied Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 019114 107 (CUSIP Number) M. Richard Cutler, Cutler Law Group, PC, 6575 West Loop South, Suite 500, Bellaire, TX 77401 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communication

ALID / Allied Corp. / Weinkauf David - SC 13G Passive Investment

Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Allied Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 019114 107 (CUSIP Number) M. Richard Cutler, Cutler Law Group, PC, 6575 West Loop South, Suite 500, Bellaire, TX 77401 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communication

Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 10, 2019 (September 10, 2019) Allied Corp. (Exact Name of Registrant as Specified in its Charter) Nevada 0-27675 33-1227173 (State or Other Jurisdiction of Incorporation) (C

Reorganization Agreement among Allied Corp., Pacific Capital Investment Group, Inc., SECFAC Exchange Corp., AM (Advanced Micro) Biosciences, Inc. and shareholders of AM (Advanced Micro) Biosciences, Inc. Dated as of July 25, 2019 and as amended effective August 27, 2019 (incorporated by reference to Exhibit 10.1 of the Company’s Registration Statement filing on Form 8-K filed with the Securities and Exchange Commission on September 10, 2019)

EXHIBIT 10.1 REORGANIZATION AND STOCK PURCHASE AGREEMENT This REORGANIZATION AND STOCK PURCHASE AGREEMENT dated as of July 25, 2019 (this “Agreement”) is by and among Allied Corp. (“Allied”), Pacific Capital Investment Group, Inc. (the “Allied Shareholder”), Allied Exchange Corp. (“Allied Exchange”), AM (Advanced Micro) Biosciences, Inc. (“Acquiror”) and shareholders of Acquiror (“Acquiror Shareho

ALID / Allied Corp. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 Commission File Number 000-56002 ALLIED CORP. (FORMERLY COSMO VENTURES Inc.) (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of i

ALID / Allied Corp. NT 10-Q - - NT 10-Q

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number 0-27675 (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: June 30, 2019 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14A-6(E)(2)) x Definitive Proxy State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14A-6(E)(2)) x Def

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2019 or ? TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission File No. 333-188873 COSMO VENTURES INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2018 Commission File Number 000-56002 COSMO VENTURES Inc. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or orga

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A/A (Amendment No. 1) FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) or 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 COSMO VENTURES INC. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A/A (Amendment No. 1) FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) or 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 COSMO VENTURES INC. (Exact name of Registrant as specified in its charter) Nevada 33-1227173 (State of Incorporation) (I.R.S. Employer Identification No.) 112 North Curry Stre

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) or 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 COSMO VENTURES INC. (Exact name of Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) or 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 COSMO VENTURES INC. (Exact name of Registrant as specified in its charter) Nevada 33-1227173 (State of Incorporation) (I.R.S. Employer Identification No.) 112 North Curry Street, Carson City, Nev

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 Commission File Number 333-1888873 COSMO VENTURES Inc. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 Commission File Number 333-1888873 COSMO VENTURES Inc. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organi

Letter from GBH CPAs, PC ("GBH") to the Securities and Exchange Commission dated August 8, 2018

EXHIBIT 16.1 United States Securities and Exchange Commission Office of the Chief Accountant 100 F Street NE Washington, DC 20549 Ladies and Gentleman: We have read the statements under Item 4.01 in the Form 8-K dated August 7, 2018, of Cosmo Ventures, Inc. (the ?Company?) to be filed with the Securities and Exchange Commission and we agree with such statements therein as related to our firm. We h

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported) August 7, 2018 Commission File Number: 333-188873 COSMO VENTURES INC. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State of Incorporation) (IRS Employer Id

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended March 31, 2018 or o TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission File No. 333-188873 COSMO VENTURES INC.

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: June 8, 2018 COSMO VENTURES INC. (Exact name of registrant as specified in its charter) Nevada 333-1888873 33-12227173 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identificati

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 28, 2018 Date of Report (Date of earliest event reported) COSMO VENTURES INC. (Exact name of registrant as specified in its charter) Nevada 333-1888873 33-1227173 (State or other jurisdiction of incorporation) (Commission Fi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2017 Commission File Number 333-1888873 COSMO VENTURES INC. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or or

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2017 Commission File Number 333-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2017 Commission File Number 333-1888873 COSMO VENTURES INC. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 Commission File Number 333-188887

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 Commission File Number 333-1888873 COSMO VENTURES INC. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended March 31, 2017 or o TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission File No. 333-188873 COSMO VENTURES INC.

ALID / Allied Corp. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2016 Commission File Number 333-1888873 COSMO VENTURES Inc. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or or

ALID / Allied Corp. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 Commission File Number 333-1888873 COSMO VENTURES INC. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or o

ALID / Allied Corp. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 Commission File Number 333-1888873 COSMO VENTURES INC. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organi

ALID / Allied Corp. 10-K - Annual Report - FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended March 31, 2016 or o TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission File No. 333-188873 COSMO VENTURES INC.

ALID / Allied Corp. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2015 Commission File Number 333-1888873 COSMO VENTURES Inc. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or or

ALID / Allied Corp. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 Commission File Number 333-1888873 COSMO VENTURES INC. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or o

ALID / Allied Corp. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 Commission File Number 333-1888873 COSMO VENTURES INC. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State or other jurisdiction of incorporation or organi

ALID / Allied Corp. 10-K - Annual Report - FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended March 31, 2015 or o TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transaction period from to Commission File No. 333-188873 COSMO VENTURES INC.

Letter from David A. Aronson, CPA, P.A. to the Securities and Exchange Commission dated December 14, 2016

EXHIBIT 16.1 DAVID A. ARONSON, CPA, P.A. 17071 West Dixie Highway Suite 301 North Miami Beach, FL 33160 December 14, 2016 United States Securities & Exchange Commission 100 F Street, NE Washington, D.C 20549 Ladies & Gentlemen: We have read the disclosures on the Form 8-K report of Cosmo Ventures, Inc. dated December 14, 2016 and we are in agreement with the statements contained therein, as they p

Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported) December 14, 2016 Commission File Number: 333-188873 COSMO VENTURES INC. (Exact name of registrant as specified in its charter) Nevada 33-1227173 (State of Incorporation) (IRS Employer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-188873 (Check One) [ ] Form 10-K [X] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended March 31, 2015 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Amendment No. 1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2014 [ ] TRANSI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Amendment No. 1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2014 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-18

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2014 [ ] TRANSITION REPORT PURS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2014 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-188873 COSMO VENTU

ALID / Allied Corp. NT 10-Q - - COSMONT10QDEC14

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-188873 (Check One) [ ] Form 10-K [X] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended December 31, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Rep

SUPPLEMENT NO. 1 DATED NOVEMBER 18, 2014 TO PROSPECTUS DATED DECEMBER 24, 2013. COSMO VENTURES, INC.

Filed pursuant to Rule 424(b)(3) Registration No. 333-188873 SUPPLEMENT NO. 1 DATED NOVEMBER 18, 2014 TO PROSPECTUS DATED DECEMBER 24, 2013. COSMO VENTURES, INC. The following information supplements the prospectus of Cosmo Ventures, Inc. dated December 24, 2013 and is part of the prospectus. This Supplement updates the information presented in the prospectus. Prospective investors should carefull

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2014 [ ] TRANSITION REPORT PUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2014 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 333-188873 COSMO VENT

ALID / Allied Corp. NT 10-Q - - COSMONT10QSEPT14

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-188873 (Check One) [ ] Form 10-K [X] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended September 30, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Re

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 [ ] TRANSITION REPORT UNDER SEC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 or [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-188873 COSMO VENTURES, INC. (E

ALID / Allied Corp. NT 10-Q - - COSNT10QJUN2014

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-188873 (Check One) [ ] Form 10-K [X] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended June 30, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10K [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year end March 31, 2014 [ ] TRANSITION REPORT UNDER SECTION 13

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10K [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year end March 31, 2014 or [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-188873 COSMO VENTURES, INC. (Exact na

ALID / Allied Corp. NT 10-K/A - - COSNT10KMAR2014.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 Amendment No.1 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-188873 (Check One) [ ] Form 10-K [X] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended March 31, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Tr

ALID / Allied Corp. NT 10-K - - COSNT10KMAR2014.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-188873 (Check One) [ ] Form 10-K [X] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended March 31, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2013 [ ] TRANSITION REPORT UNDER

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2013 or [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 333-188873 COSMO VENTURES, INC

-

Cosmo Ventures Inc 1516 Tropicana Ave, Suite 155 Las Vegas, Nevada 89119 Telephone: (702) 922-7109 (Address and telephone number of principal executive offices) January 13, 2014 Via EDGAR Scott Anderegg United States Securities and Exchange Commission 100 F Street, N.

-

December 24, 2013 Via EDGAR Scott Anderegg United States Securities and Exchange Commission 100 F Street, N.

- CVS1A3

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 Amendment No. 3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cosmo Ventures Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) 5961 (Primary Standard Industrial Classification Code Number) 33-1227173 (I.R.S. Employer Identification Number) VPO

- CVS1A2

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 Amendment No. 2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cosmo Ventures Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) 5961 (Primary Standard Industrial Classification Code Number) 33-1227173 (I.R.S. Employer Identification Number) VPO

-

December 6, 2013 Via EDGAR Scott Anderegg United States Securities and Exchange Commission 100 F Street, N.

-

November 1, 2013 Via EDGAR Scott Anderegg United States Securities and Exchange Commission 100 F Street, N.

SUBSCRIPTION AGREEMENT Cosmo Ventures Inc. 1516 E. Tropicana Ave., Suite 155 Las Vegas, NV 89119

SUBSCRIPTION AGREEMENT Cosmo Ventures Inc. 1516 E. Tropicana Ave., Suite 155 Las Vegas, NV 89119 A. Instructions. Each person considering subscribing for common shares of the Company should review the following instructions: 1. Subscription Agreement: Please complete, execute and deliver to the Company the enclosed copy of the Subscription Agreement. The Company will review the materials and, if t

- CVS1A1

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 /A Amendment No. 1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cosmo Ventures Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) 5 961 (Primary Standard Industrial Classification Code Number) 33-1227173 (I.R.S. Employer Identification Number)

Articles of Incorporation of Registrant (incorporated by reference to Exhibit 3.1(i) of the Company’s Registration Statement filing on Form S-1 filed with the Securities and Exchange Commission on May 28, 2013)

CORPORATE CHARTER I, ROSS MILLER, the duly elected and qualified Nevada Secretary of State, do hereby certify that COSMO VENTURES INC, did on February 3, 2013, file in this office the original Articles of Incorporation; that said Articles of Incorporation are now on file and of record in the office of the Secretary of State of the State of Nevada, and further, that said Articles contain all the provisions required by the law of said State of Nevada.

Bylaws of Registrant (incorporated by reference to Exhibit 3.1(ii) of the Company’s Registration Statement filing on Form S-1 filed with the Securities and Exchange Commission on May 28, 2013)

BYLAWS OF COSMO VENTURES INC. February 3, 2013 ARTICLE I OFFICES AND CORPORATE SEAL SECTION 1.1 Registered Office. Cosmo Ventures Inc., (hereinafter the “Corporation”) shall maintain a registered office in the State of Nevada. In addition to its registered office, the Corporation shall maintain a principal office at a location determined by the Board. The Board of Directors may change the Corporat

You’ve Exceeded the SEC’s Traffic Limit

Cosmo Ventures Inc 1516 E. Tropicana Ave., Unit 155 Las Vegas, Nevada 89119 Private Placement Subscription Agreement Purchaser Information Name (the “Purchaser”) Address City Province Postal Code Country Telephone Number DL/SIN/Passport # Signature of Purchaser Payment Payment Method Wire Transfer [] Check / Bank Draft / Money Order [] Number of Shares Purchased X $0.001 per share = These securiti

Registration Statement - CVS1

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Cosmo Ventures Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) 5130 (Primary Standard Industrial Classification Code Number) 33-1227173 (I.R.S. Employer Identification Number) 1516 E. Tropicana A